Search the Newsreel

Why Is TSXV: SLVR Rising Today? Key Drivers Behind Silver Tiger Metals' Strong Performance

Prestige Consumer Healthcare Inc. 2027 Q1 - Results - Earnings Call Presentation (NYSE:PBH) 2026-08-06

Prestige Consumer Healthcare Inc. (PBH) has released its Q1 2027 earnings call presentation. The company reported an EPS of $0.98, beating estimates by $0.10, and revenue of $265.71M, surpassing expectations by $15.39M, representing a 6.48% year-over-year increase. This article provides access to the slide …

Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Prestige Consumer Healthcare (PBH) reported $265.71 million in revenue for the quarter ended June 2026, representing a year-over-year increase of 6.5%. EPS of $0.98 for the same period compares to $0.95 a year ago. The reported revenue compares to the Zacks Consensus Estimate of …

CCC Intelligent Solutions Holdings (CCC) Performance Solid, But Prospective Returns Dwindle

Conestoga Capital Advisors, an asset management company, reported a positive shift towards Small Caps in its Q2 2026 investor letter. Despite a strong market for the Russell 2000 Growth Index, Conestoga's quality-focused strategies were impacted by uneven leadership, mirroring the Tech Bubble. The firm …

HC Wainwright Predicts Precigen's Q4 Earnings (NASDAQ:PGEN)

Prestige Consumer Healthcare (PBH) Q1 Earnings and Revenues Surpass Estimates

Prestige Consumer Healthcare (NYSE: PBH) awards director 2,981 RSUs

Prestige Consumer Healthcare (NYSE: PBH) director Dawn M. Zier was granted 2,981 restricted stock units (RSUs) as part of the company's director compensation program. The RSUs, valued at $155,000 based on a $52.00 closing stock price, will vest on the first anniversary of the …

Earnings Flash (PBH) Prestige Consumer Healthcare Inc. Reports Q1 Revenue $265.7M, vs. FactSet Est of $250.3M

Prestige Consumer Healthcare Inc. (PBH) reported its Q1 revenue of $265.7 million, surpassing FactSet's estimate of $250.3 million. This positive earnings flash was published on August 6, 2026, and also follows an earlier report of the company raising its earnings guidance for fiscal year …

Prestige Consumer Healthcare Inc. Reports Fiscal 2027 First Quarter Results

Prestige Consumer Healthcare Inc. reported strong first-quarter fiscal 2027 results, exceeding sales and earnings expectations with a revenue of $265.7 million, up 6.5%, and organic sales growth of 3.2%. The company closed the Breathe Right® and LaCorium acquisitions, which contributed to its performance and …

Discipline and Rules-Based Execution in RGTI Response

This article analyzes Rigetti Computing Inc. (NASDAQ: RGTI) using AI models, identifying strong near and mid-term sentiment but a weak long-term outlook. It highlights support testing, potential resistance, and an exceptional risk-reward setup targeting a significant gain with minimal risk. Three distinct trading strategies …

Morgan Stanley Maintains VERSIGENT PLC(VGNT.US) With Buy Rating, Raises Target Price to $58

Morgan Stanley has reiterated its "Buy" rating on VERSIGENT PLC (VGNT.US) and increased its target price for the company's shares to $58. This indicates a continued positive outlook from the investment bank regarding VERSIGENT's future performance.

Versigent PLC Stock 12‑Month Price Target Raised to $55.9, Implies 22% Upside

Versigent PLC (VGNT) has seen its average 12-month price target increase to $55.9 from $55.2, with individual forecasts ranging from $52 to $60. This new target suggests a 22% potential upside based on the Aug. 4 closing price. The stock maintains a "Buy" consensus …

H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57

H.C. Wainwright has reiterated its Buy rating for Rigel Pharmaceuticals (RIGL.US), maintaining a target price of $57. This indicates a continued positive outlook from the analyst firm regarding the company's stock performance.

Rigel Pharmaceuticals (RIGL) Stock Rally Runs Into Earnings Quality Doubts

Rigel Pharmaceuticals (RIGL) saw its stock rally after its Q2 earnings release, with a 4.6% increase following a strong three-month run. The company maintained profitability with $17.3m in net income and $78.7m in total revenue, though revenue and EPS declined significantly year-over-year. While the …

Is HPE (HPE) Using Quantum Partnerships To Deepen Its AI Infrastructure Moat?

In late July 2026, Rigetti Computing announced it would partner with Hewlett Packard Enterprise and the Pittsburgh Supercomputing Center to build TangleLab, a hybrid quantum-classical supercomputing testbed funded by a US$5.00 million National Science Foundation grant and slated to begin construction in September 2026. …

UBS Group raises BeiGene (ONC.US) target price to $467, citing another earnings beat in the second quarter and naming it a top pick.

UBS Group has raised its target price for BeiGene (ONC.US) to $467, following the company's strong second-quarter earnings performance. The firm reiterated its "Buy" rating and named BeiGene as a top pick, citing its robust product pipeline and favorable market position. This upward revision …

HC Wainwright Issues Pessimistic Forecast for RIGL Earnings

Rigetti Computing (NASDAQ: RGTI) reports higher Q2 2026 sales and deeper loss

Rigetti dips after reporting mixed Q2 financial results

Versigent Ord Shs When Issued (VGNT) Earnings Forecast: Future EPS & Revenue Growth Estimates

BioLife Solutions (NASDAQ: BLFS) plans cash-stock merger with Repligen

Beigene Ltd (ONC) Earnings Forecast: Future EPS & Revenue Growth Estimates

Empowered Funds LLC Takes Position in Rigel Pharmaceuticals, Inc. $RIGL

Precigen (PGEN) Stock Rallies As PAPZIMEOS Delivers First Clean Profit

Precigen (PGEN) stock rallied 5.5% after the company reported its first profitable quarter, driven by strong sales of its new therapy, PAPZIMEOS, for recurrent respiratory papillomatosis. Q2 revenue reached US$55 million, with PAPZIMEOS contributing US$53.1 million, resulting in a net income of US$20.1 million. …

Rigetti Computing (NASDAQ:RGTI) Shares Down 3.8% - Time to Sell?

Rigetti Computing (NASDAQ:RGTI) shares dropped 3.8% to $16.78, falling below key moving averages, despite a substantial 198.9% year-over-year revenue increase and beating earnings expectations. The company, however, continues to report significant losses, and insiders have sold approximately $17.5 million in stock over the past …

California State Teachers Retirement System Raises Holdings in Repligen Corporation $RGEN

The California State Teachers Retirement System increased its stake in Repligen Corporation (NASDAQ:RGEN) by 22.1% in the first quarter, now holding 61,860 shares valued at $7.3 million. Repligen exceeded analyst expectations with quarterly revenue of $204.13 million and earnings of $0.54 per share, and …

Germantown biopharma Precigen turns first quarterly profit after key drug scores FDA approval

Germantown-based biopharma company Precigen Inc. has reported its first quarterly profit. This achievement comes a year after its immunotherapy drug received FDA approval, with sales of the drug being the main driver of the profit.

Rigel Pharmaceuticals: The Easy Money Has Been Made (Rating Downgrade)

Intelligent Bio Solutions Completes Usability Study for Fingerprinting Drug Screen; 510(k) on Track

Intelligent Bio Solutions (INBS) has successfully completed a usability study for its Intelligent Fingerprinting Drug Screening System, demonstrating that non-specialist operators can accurately administer the system. This study, which involved 15 trained operators and followed FDA and ICH GCP standards, supports the company's 510(k) …

Intelligent Bio Solutions completes usability study for FDA filing

Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced the successful completion of a usability study for its Intelligent Fingerprinting Drug Screening System. This study is a critical component of its FDA 510(k) submission for U.S. market clearance, specifically to detect the opiate codeine. The results demonstrated …

CCC Intelligent Solutions (NASDAQ: CCC) holder reports small Principal Global Investors stake

Principal Global Investors has reported a small stake in CCC Intelligent Solutions Holdings Inc. (NASDAQ: CCC) through a Schedule 13G/A filing. The firm beneficially owns 6,646 shares, representing 0% of the class, all with shared voting and dispositive power. This filing indicates that Principal …

Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap Up on Earnings Beat

BeOne Medicines Ltd. - Sponsored ADR (ONC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

BeOne Medicines Ltd. - Sponsored ADR (ONC) reported $1.71 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 29.6%. EPS of $2.05 for the same period compares to $0.84 a year ago. The reported revenue represents a surprise of …

15 Operators Used Intelligent Bio Solutions' Drug Test Without Lab Training

Intelligent Bio Solutions (Nasdaq: INBS) announced the successful completion of a Usability Study for its Intelligent Fingerprinting Drug Screening System. The study confirmed that 15 non-specialist operators could accurately administer the drug test, supporting its FDA 510(k) submission for U.S. market clearance to detect …

BeiGene's H1 Net Profit Surges 627% to 3.27 Billion Yuan; Full-Year Revenue Guidance Raised to 46.2 Billion Yuan

BeiGene reported a significant surge in its H1 2026 net profit, increasing by 627% to 3.27 billion yuan, driven primarily by strong global sales of its core product, Brukinsa. The company has also raised its full-year revenue guidance to a range of 44.9 billion …

Moody National Bank Trust Division Makes New Investment in Repligen Corporation $RGEN

Moody National Bank Trust Division has acquired a new stake in Repligen Corporation (NASDAQ:RGEN), purchasing 17,728 shares valued at approximately $2.42 million. This investment comes as institutional investors collectively own 97.64% of the biotechnology company. Repligen recently reported strong quarterly earnings, exceeding analyst expectations …